Ergoteles LLC Vbi Vaccines Inc Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.38 - $22.5 $55,948 - $3.31 Million	147,233 Added 219.96%	214,169 $83,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $363,026 - $11.6 Million	-497,296 Reduced 88.14%	66,936 $47,000
Q2 2022 Aug 12, 2022	BUY	$0.66 - $1.81 $229,121 - $628,348	347,154 Added 159.92%	564,232 $456,000
Q1 2022 May 13, 2022	BUY	$1.27 - $2.47 $275,689 - $536,182	217,078 New	217,078 $360,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $378,190 - $551,028	-171,127 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $479,155 - $636,592	171,127 New	171,127 $532,000
Q4 2020 Feb 11, 2021	SELL	$2.15 - $3.5 $87,290 - $142,100	-40,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $112,462 - $250,502	40,600 New	40,600 $116,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.